You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Proposed Consensus Statement on Defining Psychedelic Drugs

Psychedelic Medicine

Journal indexing and metrics

Journal Homepage Submission guidelines

Restricted access

Research article

First published online March, 2023

Proposed Consensus Statement on Defining Psychedelic Drugs

, , and

Volume 1, Issue 1

https://doi.org/10.1089/psymed.2022.0008

Abstract

Get full access to this article

View all access options for this article.

References

1.

Liechti

ME

, Saur

MR

, Gamma

A

, et al. Psychological and physiological effects of MDMA (“Ecstasy”) after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans. Neuropsychopharmacology, 2000; 23(4):396–404.

2.

Anderson

GM

, III, Braun

G

, Braun

U

, et al. Absolute configuration and psychotomimetic activity. NIDA Res Monogr, 1978; 22:8–15.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

The Adequacy of Commitment Evaluations Performed by Psychiatric and Non-psychiatric Physicians

Retricted access

MADD Massachusetts Versus Senator Burke: A Media Advocacy Case Study

Retricted access

Retricted access

Diclofenac Increases Beta-Endorphin Plasma Concentrations